Rob Neyer wrote a piece yesterday that pointed out how differently certain systems value Raul Ibanez’s next three seasons. MGL and J.C. Bradbury both responded in the comments, as each of their valuations were discussed in the original post (J.C. had $46.5M, Lichtman had about $10M).
Here’s the problem: a player doesn’t have one fixed marginal revenue product. Instead, each player has a different MRP for every single Major League team.
This point is absolutely crucial. Raul Ibanez is not statically worth $46.5M over the next three years, or $10M, or any other number you want to throw out there. He is worth $X million to one team, $Y million to another team, $Z million to a third team, and so on.
From what I understand, the existing valuation systems (including J.C.’s, MGL’s, BP’s MORP, and others) take into account a) the player’s projected on-field value in terms of marginal wins, and b) some function of industry revenues and/or existing salaries (i.e. usually either the average amount paid per win on the free agent market, or the sport’s projected total revenues). Here are some of the key factors that they ignore:
- The team’s positional needs. If a team has Joey Gathright starting in left field, Raul Ibanez will be worth much more to them than if they have Ted Williams starting in left field.
- The team’s competitive position. Ibanez wouldn’t be of much use to the Pirates, who are nowhere near making the playoffs.
- The team’s earning potential. Teams in big markets earn more per win than teams in small markets, and are therefore more likely to offer higher salaries to free agents.
So if the Phillies’ next best option to play left field had been, let’s say, Reggie Abercrombie, and they felt they needed only a 2-3 win upgrade to make the playoffs, Ibanez might really be worth $10 million (in fact, in that situation he probably would be worth much more than that). But at the same time, his value to, let’s say, the Red Sox, is basically zero, since they already have better players in left (Jason Bay) and DH (David Ortiz).
Without these team-specific factors, no MRP system can give us any real assessment of what a player is “worth.” That’s not to say the existing ones don’t have any kind of value; they might work well as a predictive tool, I honestly don’t know. But in actually evaluating whether a player was “overpaid” or “underpaid,” these systems are far too simple.
Feedback? Write a comment, or e-mail the author at shawn(AT)squawkingbaseball.com
Add New Comment